{
    "clinical_study": {
        "@rank": "35090", 
        "arm_group": [
            {
                "arm_group_label": "zero ischemia laparoscopic RFA assisted TE", 
                "arm_group_type": "Experimental", 
                "description": "RFA will be performed for 1 to 4 cycles for 4 to 12 minutes each depending on tumor size and depth. The tumor then will be laparoscopic enucleation without hilar clamping."
            }, 
            {
                "arm_group_label": "conventional laparoscopic partial nephrectomy", 
                "arm_group_type": "Active Comparator", 
                "description": "Renal hilum will be accurately isolated and then the artery only will be clamped during surgery."
            }
        ], 
        "brief_summary": {
            "textblock": "To evaluate the feasibility and ef\ufb01ciency of zero ischemia laparoscopic radio frequency\n      ablation assisted enucleation of T1a renal cell carcinoma in comparison with the\n      conventional laparoscopic partial nephrectomy."
        }, 
        "brief_title": "Zero Ischemia Laparoscopic Radio Frequency Ablation Assisted Enucleation of Renal Cell Carcinoma With T1a Stage", 
        "completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Renal Cell Carcinoma", 
            "Zero Ischemia"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Carcinoma", 
                "Carcinoma, Renal Cell", 
                "Ischemia"
            ]
        }, 
        "detailed_description": {
            "textblock": "Warm ischemic injury is one of the most important factors affecting renal function in\n      partial nephrectomy (PN). Zero ischemia partial nephrectomy technique using renal arterial\n      branch microdissection could protect renal function during surgery, but it requires longer\n      operative time and more blood loss than conventional partial nephrectomy. The technique of\n      zero ischemia laparoscopic radio frequency ablation assisted enucleation of renal cell\n      carcinoma appears to be an alternative that eliminates warm ischemia, preserves the maximal\n      parenchyma and is oncologically safe. Our study was designed to evaluate this technique in\n      comparison with the conventional laparoscopic partial nephrectomy."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  patients with sporadic, unilateral, newly diagnosed T1a presumed renal cell carcinoma\n\n          -  patients with normal contralateral renal function (di\ufb00erential renal function of >40%\n             as determined by radionuclide scintigraphy)\n\n          -  patients agreeable to participate in this long-term follow-up study\n\n        Exclusion Criteria:\n\n          -  patients' aged >80 years\n\n          -  patients with other renal diseases\n\n          -  patients not able to tolerate the laparoscopic procedure\n\n          -  patients with previous renal surgery or history of any in\ufb02ammatory conditions of the\n             operative kidney\n\n          -  patients with the renal tumor close to the calyces"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "15 Years"
        }, 
        "enrollment": {
            "#text": "90", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 14, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01838720", 
            "org_study_id": "RenJiH-20130406"
        }, 
        "intervention": [
            {
                "arm_group_label": "zero ischemia laparoscopic RFA assisted TE", 
                "intervention_name": "zero ischemia laparoscopic RFA assisted TE", 
                "intervention_type": "Procedure", 
                "other_name": "zero ischemia laparoscopic radio frequency ablation assisted tumor enucleation"
            }, 
            {
                "arm_group_label": "conventional laparoscopic partial nephrectomy", 
                "description": "conventional laparoscopic partial nephrectomy", 
                "intervention_name": "ischemia", 
                "intervention_type": "Procedure", 
                "other_name": "renal artery will be clamped during surgery."
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "renal cell carcinoma", 
            "ischemia", 
            "radio frequency ablation"
        ], 
        "lastchanged_date": "April 20, 2013", 
        "location": {
            "contact": {
                "email": "yrhuangrenji@163.com", 
                "last_name": "Yiran Huang, M.D.", 
                "phone": "86-13501835219"
            }, 
            "facility": {
                "address": {
                    "city": "Shanghai", 
                    "country": "China", 
                    "state": "Shanghai", 
                    "zip": "200127"
                }, 
                "name": "RenJi Hospital"
            }, 
            "investigator": {
                "last_name": "Yiran Huang, M.D.", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "2", 
        "official_title": "Zero Ischemia Laparoscopic Radio Frequency Ablation Assisted Enucleation of Renal Cell Carcinoma With T1a Stage : Clinical Outcomes of a Randomised Controlled Trial", 
        "overall_contact": {
            "email": "yrhuangrenji@163.com", 
            "last_name": "Yiran Huang, M.D.", 
            "phone": "86-13501835219"
        }, 
        "overall_official": {
            "affiliation": "RenJi Hospital", 
            "last_name": "Yiran Huang, M.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "China: Ethics Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "6 months minus baseline", 
            "measure": "the absolute change in glomerular \ufb01ltration rate (GFR) of the a\ufb00ected kidney", 
            "safety_issue": "Yes", 
            "time_frame": "baseline and 6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01838720"
        }, 
        "responsible_party": {
            "investigator_affiliation": "RenJi Hospital", 
            "investigator_full_name": "Yiran Huang", 
            "investigator_title": "Principal Investigator", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "estimated GFR (eGFR)", 
                "safety_issue": "Yes", 
                "time_frame": "6 months"
            }, 
            {
                "measure": "changes in GFR of total kidneys by renal scintigraphyby", 
                "safety_issue": "Yes", 
                "time_frame": "baseline and 6 months"
            }, 
            {
                "measure": "blood loss", 
                "safety_issue": "Yes", 
                "time_frame": "during surgery"
            }, 
            {
                "description": "pathologic confirm of surgical margin", 
                "measure": "surgical margin", 
                "safety_issue": "Yes", 
                "time_frame": "postoperative"
            }, 
            {
                "measure": "postoperative complications", 
                "safety_issue": "Yes", 
                "time_frame": "6 months"
            }, 
            {
                "measure": "progression-free survival", 
                "safety_issue": "Yes", 
                "time_frame": "6 months"
            }, 
            {
                "measure": "local recurrence", 
                "safety_issue": "Yes", 
                "time_frame": "6 months"
            }
        ], 
        "source": "RenJi Hospital", 
        "sponsors": {
            "collaborator": {
                "agency": "National Natural Science Foundation of China", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "RenJi Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2013"
    }
}